Evidence map›Paper›PMID 42424119›Full record

ArticleStatistics in medicine2026

Transformation Discriminant Analysis for Constructing Optimal Biomarker Combinations.

Ainesh Sewak, Sandra Siegfried, Torsten Hothorn

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ainesh SewakDepartment of Clinical Research, Universität Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0003-1858-9987
Sandra SiegfriedInstitut für Epidemiologie, Biostatistik Und Prävention, Universität Zürich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-7312-1001
Torsten HothornInstitut für Epidemiologie, Biostatistik Und Prävention, Universität Zürich, Zürich, Switzerland.ORCID https://orcid.org/0000-0001-8301-0471

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 200021_219384
6 · The paper itself

Abstract

Accurate diagnostic tests are essential for effective screening and treatment. However, individual biomarkers often fail to provide sufficient diagnostic accuracy, as they typically capture only one aspect of the complex disease process. Combining multiple biomarkers, each capturing a distinct mechanism, can help construct more informative diagnostic tests. In practice, logistic regression is used as the default to combine biomarkers, but it can perform poorly when biomarker distributions exhibit skewness or differ across disease groups. Nonparametric methods provide more flexibility but generally require large sample sizes that are infrequently available in biomedical research. We propose a novel framework called transformation discriminant analysis which combines biomarkers through the likelihood ratio function to construct theoretically optimal diagnostic scores. Transformation discriminant analysis (TDA) balances between flexibility and efficiency. It can accommodate a wide range of distributional shapes and disease-specific dependence structures while remaining fully parametric. This allows for likelihood inference and strong performance even in small-sample settings. We evaluate TDA through simulations and benchmark its performance against commonly used methods. Finally, we illustrate its utility in constructing an optimal diagnostic test for hepatocellular carcinoma, a disease with no single ideal biomarker. An open-source R implementation is provided for reproducibility and broader application.

Indexed as

BiomarkersDiagnostic Tests, RoutineCarcinoma, HepatocellularComputer SimulationDiscriminant AnalysisHumansLikelihood FunctionsLiver NeoplasmsLogistic ModelsModels, StatisticalReproducibility of ResultsBiomarkersAUCbiomarker combinationbiomarkersclassificationdiagnostic testshepatocellular carcinomalikelihood ratioROC

Identifiers

PMID42424119
PMCPMC13348877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.